|
Aug 4
|
Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?
|
|
Aug 4
|
Marex Group plc (MRK) to Acquire Winterflood Securities
|
|
Aug 4
|
Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas
|
|
Aug 4
|
GILD Likely to Beat on Q2 Earnings: Buy, Sell or Hold the Stock?
|
|
Aug 4
|
Michael Heinley Joins Sam Brown Healthcare Communications As Managing Director, Client Development and Engagement
|
|
Aug 4
|
Is Wall Street Bullish or Bearish on Merck Stock?
|
|
Aug 4
|
Turbine to Simulate Hard-to-Treat Cancer Populations with AI for Identification of Novel Dependencies through Collaboration with MSD
|
|
Aug 3
|
Why Drug Prices for Some Big Medicines Will Remain High for a Longer Time
|
|
Aug 3
|
This Blue-Chip Dividend Stock Is Stuck in the Tariff Crosshairs. Can Cost Cuts Save the Day?
|
|
Aug 3
|
The one-year underlying earnings growth at Merck (NYSE:MRK) is promising, but the shareholders are still in the red over that time
|
|
Aug 2
|
3 High-Yielding Dividend Stocks That Are Trading Near Their 52-Week Lows
|
|
Aug 1
|
Merck & Co., Inc. (MRK) Needs To Move On From Talking About Its Animal Division, Says Jim Cramer
|
|
Aug 1
|
MRNA Beats on Q2 Earnings & Sales, Stock Down on Lowered Sales View
|
|
Aug 1
|
Stocks to watch next week: BP, Diageo, Disney, Uber and WPP
|
|
Aug 1
|
Stock Market News for Aug 1, 2025
|
|
Aug 1
|
Reddit, Coinbase, Novo Nordisk - Trending Stocks
|
|
Aug 1
|
Testicular Cancer Market Analysis and Forecast Report 2025-2035 | Emerging Trends Highlight Shift Towards Immunotherapy in Testicular Cancer
|
|
Aug 1
|
Merck & Co. assembles an Alzheimer’s comeback with a next-gen precision focus
|
|
Aug 1
|
Jim Cramer on Merck’s Latest Quarterly Report: “I Actually Liked It”
|
|
Jul 31
|
1 Blue-Chip Dividend Stock That Still Has Room to Run
|